These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33293769)

  • 21. Effect of caloric restriction on phosphate metabolism and uremic vascular calcification.
    Vidal A; Rios R; Pineda C; Lopez I; Rodriguez M; Aguilera-Tejero E; Raya AI
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1188-F1198. PubMed ID: 32249611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Iwashita Y; Ohya M; Yashiro M; Sonou T; Kawakami K; Nakashima Y; Yano T; Iwashita Y; Mima T; Negi S; Kubo K; Tomoda K; Odamaki T; Shigematsu T
    Am J Nephrol; 2018; 47(5):325-332. PubMed ID: 29779028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism.
    McCabe KM; Zelt JG; Kaufmann M; Laverty K; Ward E; Barron H; Jones G; Adams MA; Holden RM
    J Pharmacol Exp Ther; 2018 Sep; 366(3):433-445. PubMed ID: 29903718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.
    Adema AY; de Borst MH; Ter Wee PM; Vervloet MG;
    J Ren Nutr; 2014 May; 24(3):143-50. PubMed ID: 24216259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
    Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
    Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-
    Voelkl J; Tuffaha R; Luong TTD; Zickler D; Masyout J; Feger M; Verheyen N; Blaschke F; Kuro-O M; Tomaschitz A; Pilz S; Pasch A; Eckardt KU; Scherberich JE; Lang F; Pieske B; Alesutan I
    J Am Soc Nephrol; 2018 Jun; 29(6):1636-1648. PubMed ID: 29654213
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease.
    Shuvy M; Abedat S; Eliaz R; Abu-Rmeileh I; Abu-Snieneh A; Ben-Dov IZ; Meir K; Pereg D; Beeri R; Lotan C
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H695-H704. PubMed ID: 31398059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive accumulation of lanthanum in the liver of normal and uremic rats.
    Slatopolsky E; Liapis H; Finch J
    Kidney Int; 2005 Dec; 68(6):2809-13. PubMed ID: 16316357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic kidney disease (CKD) and bone. Vascular calcification in CKD].
    Yokoyama K
    Clin Calcium; 2009 Apr; 19(4):552-8. PubMed ID: 19329835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA; Mathew S; Davies MR; Lund RJ
    Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthraquinone-containing compound in rhubarb prevents indole production via functional changes in gut microbiota.
    Takayama K; Maehara S; Tabuchi N; Okamura N
    J Nat Med; 2021 Jan; 75(1):116-128. PubMed ID: 33078328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperphosphatemia Drives Procoagulant Microvesicle Generation in the Rat Partial Nephrectomy Model of CKD.
    Abbasian N; Goodall AH; Burton JO; Bursnall D; Bevington A; Brunskill NJ
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33139598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification.
    Iida A; Kemmochi Y; Kakimoto K; Tanimoto M; Mimura T; Shinozaki Y; Uemura A; Matsuo A; Matsushita M; Miyamoto K
    Am J Nephrol; 2013; 37(4):346-58. PubMed ID: 23548309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
    Yu L; Tomlinson JE; Alexander ST; Hensley K; Han CY; Dwyer D; Stolina M; Dean C; Goodman WG; Richards WG; Li X
    Calcif Tissue Int; 2017 Dec; 101(6):641-653. PubMed ID: 29038882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.